Plain-English translation of NCT07635641 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
REPROton-HN is a study following patients who receive proton therapy to treat head and neck cancer that has returned after prior radiation treatment. Proton therapy is a precise form of radiation that targets tumors while sparing nearby healthy tissues. The study will track how well this treatment works, what side effects occur, and how it affects quality of life.
Some patients with head and neck cancer develop tumors that come back in areas already treated with radiation, making surgery difficult or impossible. Standard radiation therapy can be risky because surrounding organs and tissues have already received high radiation doses, so doctors need better information about whether and how proton therapy can safely help these patients.
You likely qualify if…
You likely don't qualify if…
You will receive proton therapy treatment for your recurrent tumor, with the research team carefully monitoring your progress throughout and after treatment. The study will track your side effects, how well the tumor responds, your survival, and your quality of life over time. You will likely have regular follow-up visits and may complete questionnaires or imaging scans as part of the monitoring process.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Italy